Rock Springs Capital Management LP 13D and 13G filings for Agios Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-02-14 2:06 pm Sale |
2023-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
Rock Springs Capital Management LP | 2,152,173 3.850% |
-844,419![]() (-28.18%) |
Filing |
2023-02-14 2:50 pm Purchase |
2022-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
Rock Springs Capital Management LP | 2,996,592 5.450% |
2,996,592![]() (New Position) |
Filing |